Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
about
Endoscope-guided interstitial intensity-modulated brachytherapy and intracavitary brachytherapy as boost radiation for primary early T stage nasopharyngeal carcinoma.Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional dataHealth-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapyNasopharyngeal carcinoma: treatments and outcomes in the 20th century.A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort.Statistical analysis of IMRT dosimetry quality assurance measurements for local delivery guideline.Concurrent chemotherapy for T4 classification nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.A dosimetric comparison of two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal cancer.Clinical use of intensity-modulated radiotherapy: part I.Phase II trial of concurrent chemoradiotherapy with S-1 versus weekly cisplatin for locoregionally advanced nasopharyngeal carcinoma.State-of-the-art management of nasopharyngeal carcinoma: current and future directionsIntensity-modulated radiation therapy in the treatment of head and neck cancer.Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers.Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.Advances in radiation therapy of head and neck cancer.IMRT for head and neck cancer: reducing xerostomia and dysphagia.High-risk factors of parotid lymph node metastasis in nasopharyngeal carcinoma: a case-control study.The treatment outcome and radiation-induced toxicity for patients with head and neck carcinoma in the IMRT era: a systematic review with dosimetric and clinical parameters.Planning and delivery of intensity-modulated radiation therapy.A systematic review of trismus induced by cancer therapies in head and neck cancer patients.A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact.Organ-sparing radiation therapy for head and neck cancer.Nutlin-3, A P53-Mdm2 Antagonist For Nasopharyngeal Carcinoma Treatment.Experimental studies on the inhibition of adenovirus-ING4-OSM therapy on nasopharyngeal carcinoma proliferation in vitro and in vivo.The Outcome of the First 100 Nasopharyngeal Cancer Patients in Thailand Treated by Helical TomotherapyMRI to delineate the gross tumor volume of nasopharyngeal cancers: which sequences and planes should be used?Impact of geometric uncertainties on dose distribution during intensity modulated radiotherapy of head-and-neck cancer: the need for a planning target volume and a planning organ-at-risk volume.Peripheral dose from megavoltage cone-beam CT imaging for nasopharyngeal carcinoma image-guided radiation therapy.Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience.Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis.Network-level dysconnectivity in patients with nasopharyngeal carcinoma (NPC) early post-radiotherapy: longitudinal resting state fMRI study.Intensity-modulated radiotherapy for elderly patients with nasopharyngeal carcinoma.Comparison of intensity modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and a 3-dimensional conformal parotid gland-sparing radiotherapy (ConPas 3D-CRT) in treatment of nasopharyngeal carcinoma: a mono-institutional experience.Prognostic value of quality of life measured after treatment on subsequent survival in patients with nasopharyngeal carcinoma.Prevention of radiation-induced xerostomia by submandibular gland transfer.Long-term treatment results for nasopharyngeal carcinoma: the Sahlgrenska University Hospital experience.A simplified intensity modulated radiation therapy technique for the breast.Is daily computed tomography image guidance necessary for nasal cavity and nasopharyngeal radiotherapy? An investigation based on helical tomotherapy.
P2860
Q31152476-8FB080B1-08B0-475A-93CC-69C9CBABFFDDQ33578833-3806DD17-B844-46DE-BF03-7449486D583BQ33870454-D1377A1F-A723-4F98-83DA-CB26013F5AA9Q34069855-95A9F8F7-5E94-4F84-B77A-FCA1BF0A3ABFQ34631533-68ED566E-D92F-4F23-8A6C-C9C1707592D6Q34764855-422263BD-A0B4-4933-BE81-D14404A8AF8BQ34778388-267F8CFA-74C6-4962-92D6-DE73EF812E8BQ35154741-7AE6D7AE-4D51-4AA5-8365-0B73FEA2D402Q35591783-6F589F43-3C5D-45B1-BEEE-0372752F22F7Q35686412-0310F3B0-C3FD-4214-83D2-E896CC23CF96Q35753624-D7352EE9-CB3C-4F52-A1B8-B052F0152B6DQ36065641-5D2AF864-7111-4F8F-BBE2-23866C78E40EQ36303901-59C42F28-4AC4-4F52-9B5B-888E85D49239Q36343896-DC3526E2-761F-459B-963B-3A91A9F8EF53Q36546073-42E6956C-AB4D-4EAF-A916-D1C80C22A0A7Q37134458-DF959F27-D8A1-4AB3-B827-4277B90C3ACEQ37187245-27247B10-69AB-4FF9-AE28-1BE9974961C1Q37228349-560F1CB9-2651-4C0C-8A9A-02D51D6D6B64Q37283393-5375128D-B99D-4650-9615-BEAC902C4692Q37379087-8734A8E2-29E7-4711-9475-67A27026DD6BQ37705009-02537E49-88BE-4CA0-BC89-4DD5067BB4BDQ37711059-18F99A73-0553-459B-92AF-B9C291F76ABAQ37718044-968F9265-458F-4D98-A7E3-4519B3D4E9C8Q37905536-349A3136-D603-49A6-92C4-9C8A1671C492Q38656647-5F767FD7-3A87-4FE9-ABF8-CB07D6222438Q38977008-6CE698CD-D050-47F5-9E16-42414FF5FD45Q41678155-B3607733-AFB6-41D7-B939-A65B3779A6D5Q42747616-03482508-913A-4A9E-ACA9-63E6DFBB5650Q42747904-EB10336C-A82E-402C-94D3-2679EF7A7561Q45914162-C9307AF7-10C8-4C4D-B3CD-EFABA041CA7CQ46070865-73EF6053-8393-4719-8242-BEED59AD525DQ46771718-C27A38AB-05F7-4727-8066-D42170CF48AAQ47955620-38F0E00D-71D9-4BF1-B658-FF170749CBAEQ48272025-9CBCBC5E-8480-4474-9F92-B08A1DA1D4BAQ48378684-08600B82-9A30-46AF-B7B5-081FD7A1245CQ48433004-25DCBD2D-D0CD-4FE0-BB1E-C783665C0DD6Q48545742-7320C16D-5D8C-4234-99B4-D56830A09DFBQ50456557-1F36E9B9-39FC-40E4-9531-E889D705A59AQ53874303-067CD76B-0729-4705-863F-3FC41F45B119Q55033186-27463838-9AF4-4037-8350-5786ED34C7D6
P2860
Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Three-dimensional intensity-mo ...... rnia-San Francisco experience.
@ast
Three-dimensional intensity-mo ...... rnia-San Francisco experience.
@en
Three-dimensional intensity-mo ...... rnia-San Francisco experience.
@nl
type
label
Three-dimensional intensity-mo ...... rnia-San Francisco experience.
@ast
Three-dimensional intensity-mo ...... rnia-San Francisco experience.
@en
Three-dimensional intensity-mo ...... rnia-San Francisco experience.
@nl
prefLabel
Three-dimensional intensity-mo ...... rnia-San Francisco experience.
@ast
Three-dimensional intensity-mo ...... rnia-San Francisco experience.
@en
Three-dimensional intensity-mo ...... rnia-San Francisco experience.
@nl
P2093
P921
P1476
Three-dimensional intensity-mo ...... ornia-San Francisco experience
@en
P2093
P304
P356
10.1016/S0360-3016(00)00702-1
P407
P577
2000-10-01T00:00:00Z